Published in MMWR Morb Mortal Wkly Rep on December 23, 2011
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr (2014) 3.77
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis (2015) 2.48
Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine (2014) 2.30
An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010. Vaccine (2012) 1.87
Physicians' human papillomavirus vaccine recommendations, 2009 and 2011. Am J Prev Med (2014) 1.69
Impact of the HIV epidemic on the incidence rates of anal cancer in the United States. J Natl Cancer Inst (2012) 1.67
Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. Am J Public Health (2013) 1.57
Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis. BMJ (2015) 1.43
High rates of incident and prevalent anal human papillomavirus infection among young men who have sex with men. J Infect Dis (2013) 1.38
HPV vaccination among adolescent males: results from the National Immunization Survey-Teen. Vaccine (2013) 1.36
HPV vaccine hesitancy: findings from a statewide survey of health care providers. J Pediatr Health Care (2014) 1.31
Epidemiology and clinical aspects of HPV in head and neck cancers. Head Neck Pathol (2012) 1.29
Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines (2014) 1.26
HIV and other sexually transmitted infections among men who have sex with men recruited by RDS in Buenos Aires, Argentina: high HIV and HPV infection. PLoS One (2012) 1.22
Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis. BMC Pediatr (2012) 1.19
"1-2-3 Pap" Intervention Improves HPV Vaccine Series Completion among Appalachian Women. J Commun (2013) 1.19
Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010. Am J Public Health (2012) 1.13
Factors associated With Medicaid providers' recommendation of the HPV vaccine to low-income adolescent girls. J Adolesc Health (2013) 1.12
Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics (2012) 1.10
Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents. Pediatrics (2014) 1.09
Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage: A Systematic Review. JAMA Pediatr (2015) 1.08
Modeling preventative strategies against human papillomavirus-related disease in developed countries. Vaccine (2012) 1.08
Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol (2012) 1.06
Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis (2013) 1.05
Anal squamous cell carcinoma: an evolution in disease and management. World J Gastroenterol (2014) 1.03
Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Curr Opin Oncol (2013) 1.01
Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health (2013) 1.01
Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination. Am J Public Health (2013) 0.99
Primary prevention and vaccination for penile cancer. Ther Adv Urol (2013) 0.99
Designing messages to motivate parents to get their preteenage sons vaccinated against human papillomavirus. Perspect Sex Reprod Health (2012) 0.99
Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians. Prev Med (2013) 0.98
Prevention of HPV-related oral cancer: assessing dentists' readiness. Public Health (2014) 0.97
Association of genital human papillomavirus infection with HIV acquisition: a systematic review and meta-analysis. Sex Transm Infect (2013) 0.97
NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men. Cancer Res (2015) 0.96
Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the United States across time. Chem Res Toxicol (2014) 0.96
Human Papillomavirus Vaccination Among Young Adult Gay and Bisexual Men in the United States. Am J Public Health (2015) 0.95
Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. J Infect Dis (2012) 0.95
The road ahead for cervical cancer prevention and control. Curr Oncol (2014) 0.94
Assessing the burden of HPV-related cancers in Appalachia. Hum Vaccin Immunother (2012) 0.94
Randomized controlled trial of two dosing schedules for human papillomavirus vaccination among college age males. Vaccine (2013) 0.93
Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls. Cancer (2012) 0.93
HPV vaccination among lesbian and bisexual women: Findings from a national survey of young adults. Vaccine (2014) 0.93
Health care use and opportunities for human papillomavirus vaccination among young men who have sex with men. Sex Transm Dis (2013) 0.92
Evaluation of an intervention providing HPV vaccine in schools. Am J Health Behav (2014) 0.92
Current status of human papillomavirus vaccines. Clin Exp Vaccine Res (2014) 0.91
Human papillomavirus vaccine uptake among 9-17 year old males in the United States: the National Health Interview Survey, 2010. Hum Vaccin Immunother (2013) 0.91
Gynecologic cancer prevention and control in the National Comprehensive Cancer Control Program: progress, current activities, and future directions. J Womens Health (Larchmt) (2013) 0.91
Ohio Appalachia public health department personnel: human papillomavirus (HPV) vaccine availability, and acceptance and concerns among parents of male and female adolescents. J Community Health (2012) 0.91
Human papillomavirus infection: knowledge, attitudes, and behaviors among lesbian, gay men, and bisexual in Italy. PLoS One (2012) 0.90
Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review. Adv Ther (2015) 0.90
Barriers and facilitators to HPV vaccination: perspectives from Malawian women. Women Health (2013) 0.90
Correlates of comfort with alternative settings for HPV vaccine delivery. Hum Vaccin Immunother (2013) 0.89
Investigating stakeholder attitudes and opinions on school-based human papillomavirus vaccination programs. J Sch Health (2015) 0.87
Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age. Hum Vaccin Immunother (2014) 0.87
Incremental benefits of male HPV vaccination: accounting for inequality in population uptake. PLoS One (2014) 0.86
Intervention effects from a social marketing campaign to promote HPV vaccination in preteen boys. Vaccine (2014) 0.86
Molecular cancer prevention: Current status and future directions. CA Cancer J Clin (2015) 0.86
HPV vaccine use among African American girls: qualitative formative research using a participatory social marketing approach. Gynecol Oncol (2014) 0.86
HPV infections among MSM in Shenzhen, China. PLoS One (2014) 0.86
Validation of the Vaccination Confidence Scale: A Brief Measure to Identify Parents at Risk for Refusing Adolescent Vaccines. Acad Pediatr (2015) 0.85
HPV awareness and willingness to HPV vaccination among high-risk men attending an STI clinic in Puerto Rico. P R Health Sci J (2012) 0.85
HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital (2014) 0.85
Partnering with middle school students to design text messages about HPV vaccination. Health Promot Pract (2014) 0.85
Using Facebook™ to Recruit College-Age Men for a Human Papillomavirus Vaccine Trial. Am J Mens Health (2014) 0.85
Qualitative responses to a national physician survey on HPV vaccination. Vaccine (2013) 0.84
Revised adult immunization guideline recommended by the korean society of infectious diseases, 2014. Infect Chemother (2015) 0.84
Developing a Tablet-Based Self-Persuasion Intervention Promoting Adolescent HPV Vaccination: Protocol for a Three-Stage Mixed-Methods Study. JMIR Res Protoc (2016) 0.84
Characteristics associated with initiation of the human papillomavirus vaccine among a national sample of male and female young adults. J Adolesc Health (2013) 0.84
Accuracy of parental reports of children's HPV vaccine status: implications for estimates of disparities, 2009-2010. Public Health Rep (2014) 0.83
Recommendations for a national agenda to substantially reduce cervical cancer. Cancer Causes Control (2013) 0.83
Trends in the occurrence of high-grade anal intraepithelial neoplasia in San Francisco: 2000-2009. Cancer (2013) 0.83
Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic Review. Cancer J (2015) 0.83
HPV vaccine for teen boys: Dyadic analysis of parents' and sons' beliefs and willingness. Prev Med (2015) 0.82
Vaccination against human papilloma virus infection in male adolescents: knowledge, attitudes, and acceptability among parents in Italy. Hum Vaccin Immunother (2014) 0.82
Parents' Recall and Reflections on Experiences Related to HPV Vaccination for Their Children. Qual Health Res (2015) 0.82
Vaccinating sons against HPV: results from a U.S. national survey of parents. PLoS One (2014) 0.82
Predicting human papillomavirus vaccine intentions of college-aged males: an examination of parents' and son's perceptions. J Am Coll Health (2012) 0.82
Quadrivalent human papillomavirus vaccine uptake in adolescent boys and maternal utilization of preventive care and history of sexually transmitted infections. Am J Public Health (2013) 0.82
Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases. Hum Vaccin Immunother (2016) 0.82
Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model. Infect Agent Cancer (2014) 0.81
Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program. BMC Infect Dis (2014) 0.81
Human papillomavirus vaccination: current indications and future directions. Obstet Gynecol Clin North Am (2013) 0.81
Promotora Outreach, Education and Navigation Support for HPV Vaccination to Hispanic Women with Unvaccinated Daughters. J Cancer Educ (2015) 0.81
Impact of a physician recommendation. Hum Vaccin Immunother (2014) 0.81
Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among men who have sex with men in Hong Kong. PLoS One (2013) 0.81
HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011. Vaccine (2014) 0.81
The role of sexual behavior in head and neck cancer: implications for prevention and therapy. Expert Rev Anticancer Ther (2014) 0.81
Adolescent Male Human Papillomavirus Vaccination. Glob Pediatr Health (2016) 0.80
Seroprevalence and seroincidence of herpes simplex virus (2006-2010), syphilis (2006-2010), and vaccine-preventable human papillomavirus subtypes (2000-2010) among US military personnel. Sex Transm Dis (2015) 0.80
Acceptability of HPV vaccine for males and preferences for future education programs among Appalachian residents. Am J Mens Health (2013) 0.80
Early adoption of the human papillomavirus vaccine among Hispanic adolescent males in the United States. Cancer (2014) 0.80
Insights in public health: The hidden epidemic: sexually transmitted diseases in 2014. Hawaii J Med Public Health (2014) 0.80
Predictors of Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men. Sex Transm Dis (2016) 0.80
Ethical considerations of universal vaccination against human papilloma virus. BMC Med Ethics (2014) 0.79
Pros, cons, and ethics of HPV vaccine in teens-Why such controversy? Transl Androl Urol (2014) 0.79
What parents and adolescent boys want in school vaccination programs in the United States. J Adolesc Health (2013) 0.79
Human Papillomavirus Vaccine Uptake After a Tailored, Online Educational Intervention for Female University Students: A Randomized Controlled Trial. J Womens Health (Larchmt) (2015) 0.79
Improving Human Papillomavirus (HPV) Vaccination in the Postpartum Setting. J Community Health (2017) 0.78
Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep (2006) 37.28
Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep (2009) 17.76
Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep (2010) 14.85
Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep (2008) 13.54
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20
Youth risk behavior surveillance - United States, 2011. MMWR Surveill Summ (2012) 11.57
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep (2009) 11.30
Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ (2014) 11.24
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59
Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep (2009) 9.94
Outbreak of West Nile-like viral encephalitis--New York, 1999. MMWR Morb Mortal Wkly Rep (1999) 9.67
Youth risk behavior surveillance - United States, 2009. MMWR Surveill Summ (2010) 9.63
Advancing HIV prevention: new strategies for a changing epidemic--United States, 2003. MMWR Morb Mortal Wkly Rep (2003) 9.37
Youth risk behavior surveillance--United States, 2007. MMWR Surveill Summ (2008) 9.04
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep (2008) 9.02
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. MMWR Morb Mortal Wkly Rep (2011) 8.80
Ten great public health achievements--United States, 1900-1999. MMWR Morb Mortal Wkly Rep (1999) 8.67
Cigarette smoking among adults--United States, 2004. MMWR Morb Mortal Wkly Rep (2005) 8.60
Vital signs: current cigarette smoking among adults aged ≥18 years--United States, 2005-2010. MMWR Morb Mortal Wkly Rep (2011) 8.45
Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999. MMWR Morb Mortal Wkly Rep (2002) 8.37
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep (2010) 8.16
Cigarette smoking among adults--United States, 2006. MMWR Morb Mortal Wkly Rep (2007) 8.14
Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001. MMWR Morb Mortal Wkly Rep (2005) 8.10
Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep (2009) 8.03
Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep (2006) 7.90
HIV prevalence estimates--United States, 2006. MMWR Morb Mortal Wkly Rep (2008) 7.76
Staphylococcus aureus resistant to vancomycin--United States, 2002. MMWR Morb Mortal Wkly Rep (2002) 7.34
Cigarette smoking among adults--United States, 2000. MMWR Morb Mortal Wkly Rep (2002) 7.32
Notes from the field: electronic cigarette use among middle and high school students - United States, 2011-2012. MMWR Morb Mortal Wkly Rep (2013) 7.28
HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men--five U.S. cities, June 2004-April 2005. MMWR Morb Mortal Wkly Rep (2005) 7.25
Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep (1995) 7.11
Quitting smoking among adults--United States, 2001-2010. MMWR Morb Mortal Wkly Rep (2011) 7.06
Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep (2010) 7.04
Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ (2009) 7.02
Vital signs: HIV prevention through care and treatment--United States. MMWR Morb Mortal Wkly Rep (2011) 6.90
Cigarette smoking among adults--United States, 2007. MMWR Morb Mortal Wkly Rep (2008) 6.82
Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009. MMWR Morb Mortal Wkly Rep (2010) 6.72
Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep (1999) 6.57
Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep (2001) 6.49
Prevalence and awareness of HIV infection among men who have sex with men --- 21 cities, United States, 2008. MMWR Morb Mortal Wkly Rep (2010) 6.25
Youth risk behavior surveillance--United States, 2013. MMWR Surveill Summ (2014) 6.17
Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 6.09
Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep (2009) 6.08
Tobacco use among middle and high school students - United States, 2011-2014. MMWR Morb Mortal Wkly Rep (2015) 6.05
National surveillance for asthma--United States, 1980-2004. MMWR Surveill Summ (2007) 6.05
Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR Morb Mortal Wkly Rep (2009) 6.04
Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep (2008) 6.02
CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep (2012) 5.77
Cluster of severe acute respiratory syndrome cases among protected health-care workers--Toronto, Canada, April 2003. MMWR Morb Mortal Wkly Rep (2003) 5.50
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2011) 5.48
Trends in the prevalence and incidence of self-reported diabetes mellitus -- United States, 1980-1994. MMWR Morb Mortal Wkly Rep (1997) 5.45
Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis--United States, 1988-1994 and 1999-2002. MMWR Surveill Summ (2005) 5.40
Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997. MMWR Morb Mortal Wkly Rep (1997) 5.30
Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep (2009) 5.29
Severe acute respiratory syndrome--Singapore, 2003. MMWR Morb Mortal Wkly Rep (2003) 5.28
Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep (2009) 5.25
Tobacco use among adults--United States, 2005. MMWR Morb Mortal Wkly Rep (2006) 5.24
Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors--United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003-April 2005. MMWR Surveill Summ (2006) 5.15
Prevalence of disabilities and associated health conditions among adults--United States, 1999. MMWR Morb Mortal Wkly Rep (2001) 5.14
Current cigarette smoking among adults - United States, 2011. MMWR Morb Mortal Wkly Rep (2012) 5.12
Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep (2009) 5.10
Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep (2001) 4.95
Prevalence and most common causes of disability among adults--United States, 2005. MMWR Morb Mortal Wkly Rep (2009) 4.86
Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep (2011) 4.85
Nosocomial enterococci resistant to vancomycin--United States, 1989-1993. MMWR Morb Mortal Wkly Rep (1993) 4.77
Surveillance for Lyme disease--United States, 1992-2006. MMWR Surveill Summ (2008) 4.77
Barriers to children walking and biking to school--United States, 1999. MMWR Morb Mortal Wkly Rep (2002) 4.76
Subpopulation estimates from the HIV incidence surveillance system--United States, 2006. MMWR Morb Mortal Wkly Rep (2008) 4.68
Ebola viral disease outbreak--West Africa, 2014. MMWR Morb Mortal Wkly Rep (2014) 4.67
Cancer screening - United States, 2010. MMWR Morb Mortal Wkly Rep (2012) 4.64
Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. MMWR Recomm Rep (2008) 4.64
Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. MMWR Surveill Summ (2014) 4.53
Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus - United States, 2009. MMWR Morb Mortal Wkly Rep (2009) 4.50
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2014) 4.50
Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep (2009) 4.48
Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep (2012) 4.45
Current cigarette smoking among adults - United States, 2005-2012. MMWR Morb Mortal Wkly Rep (2014) 4.39
Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal Wkly Rep (2005) 4.39
Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep (2005) 4.36
Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep (2009) 4.36
Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep (2009) 4.36
FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep (2010) 4.34
HIV surveillance--United States, 1981-2008. MMWR Morb Mortal Wkly Rep (2011) 4.30
Forward: CDC Health Disparities and Inequalities Report - United States, 2011. MMWR Surveill Summ (2011) 4.29
Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010. MMWR Morb Mortal Wkly Rep (2010) 4.24
Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. MMWR Recomm Rep (2013) 4.22
National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010. MMWR Morb Mortal Wkly Rep (2011) 4.18
Trends in aging--United States and worldwide. MMWR Morb Mortal Wkly Rep (2003) 4.16
Racial/ethnic disparities in diagnoses of HIV/AIDS--33 states, 2001-2005. MMWR Morb Mortal Wkly Rep (2007) 4.16
Methicillin-resistant staphylococcus aureus infections among competitive sports participants--Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep (2003) 4.14
Community-based opioid overdose prevention programs providing naloxone - United States, 2010. MMWR Morb Mortal Wkly Rep (2012) 4.13
Ebola virus disease outbreak - Nigeria, July-September 2014. MMWR Morb Mortal Wkly Rep (2014) 4.08
Global youth tobacco surveillance, 2000-2007. MMWR Surveill Summ (2008) 3.98
Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep (2011) 3.98
Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012. MMWR Morb Mortal Wkly Rep (2013) 3.96
Update: Outbreak of severe acute respiratory syndrome--worldwide, 2003. MMWR Morb Mortal Wkly Rep (2003) 3.95
Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep (2002) 3.95
Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009. MMWR Morb Mortal Wkly Rep (2011) 3.92
Locally acquired Dengue--Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep (2010) 3.83